Netherlands Leprosy Relief

Young child with leprosy spots on his back

until No Leprosy Remains

NLR is a global forerunner in the fight for a leprosy-free world

We take pride in enabling research and driving evidence-based innovation. A recent, major, breakthrough provides hope that stopping leprosy is coming within reach. It will take joint effort but we have the ambition to continue until No Leprosy Remains.

What we achieved last year

60,041

New leprosy cases diagnosed and treated

28,390

Persons treated with preventitive medication

2,273

Children received financial support for their education

14,066

People provided with assistive devices

About us

Our priority programmes

Even today, leprosy causes disability and social exclusion. The disease affects millions of lives. NLR focuses on the four most pressing issues standing in the way of a leprosy-free world.

News

NLR continues as an alliance

In the past 50 years Netherlands Leprosy Relief has been one of the major change-makers towards a world without leprosy. In 2018 we started transforming our organisation towards an international alliance of locally embedded NGOs to better serve our mission. This new way of working as an alliance is marked with a new name. Netherlands Leprosy Relief continues as NLR.

Combined approach to reduce disabilities in Mozambique

NLR successfully completed a one year project to reduce disabilities through early case detection of leprosy, konzo and disabilities by other diseases in Mocuba, Ile and Gile districts of Zambezia province in Mozambique. This project was funded by the Australian government through its Direct Aid Program. 442 people were identified.

An alliance of partners active across five countries

  1. Brazil

    4,415 new patients diagnosed and treated

    Visit page
  2. Mozambique

    1,437 new patients diagnosed and treated

    Visit page
  3. India

    37,795 new patients diagnosed and treated

    Visit page
  4. Nepal

    910 new patients diagnosed and treated

    Visit page
  5. Indonesia

    14,363 new patients diagnosed and treated

    Visit page

Our projects

View all projects